Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results

BACKGROUND: Preoperative chemoradiotherapy with capecitabine is considered as a standard of care for locally advanced rectal cancer. The “Tratamiento de Tumores Digestivos” group (TTD) previously reported in a randomized Ph II study that the addition of Bevacizumab to capecitabine-RT conferred no di...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar, Ramón, Capdevila, Jaume, Manzano, Jose Luis, Pericay, Carles, Martínez-Villacampa, Mercedes, López, Carlos, Losa, Ferrán, Safont, María José, Gómez-España, Auxiliadora, Alonso-Orduña, Vicente, Escudero, Pilar, Gallego, Javier, García-Paredes, Beatriz, Palacios, Amalia, Biondo, Sebastiano, Grávalos, Cristina, Aranda, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694337/
https://www.ncbi.nlm.nih.gov/pubmed/33246428
http://dx.doi.org/10.1186/s12885-020-07661-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694337/
https://www.ncbi.nlm.nih.gov/pubmed/33246428
http://dx.doi.org/10.1186/s12885-020-07661-z

Ejemplares similares